Inventor

WU CHENGDE

US61 patents

⚠️ This page may combine multiple inventors who share the name “WU CHENGDE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WU CHENGDE

TEXAS BIOTECHNOLOGY CORP

Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin

Sulfonamides and derivatives thereof that modulate the activity of endothelin

N, N-disubstituted amides that inhibit the binding of integrins to their receptors

Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin

Process of preparing alkali metal salys of hydrophobic sulfonamides

Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin

Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin

Formulation of sulfonamides for treatment of endothelin-mediated disorders

Sulfonamides for treatment of endothelin-mediated disorders

N-heteroaryl aryl-substituted thienyl-furyl-and pyrrolyl-sulfonamides and derviatives thereof that modulate the activity of endothelin

Benzenesulfonamides and the use thereof to modulate the activity of endothelin

N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin

Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin

Benzenesulfonamides and the use thereof to modulate the activity of endothelin

Formulation of sulfonamides for treatment of endothelin-mediated disorders

Compounds that inhibit the binding of integrins to their receptors

Propanoic acid derivatives that inhibit the binding of integrins to their receptors

N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin

Sulfonamides and derivatives thereof that modulate the activity of endothelin

ENCYSIVE PHARMACEUTICALS INC

Sulfonamides for treatment of endothelin-mediated disorders

Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists

Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists

Carboxylic acid derivatives that inhibit the binding of integrins to their receptors

Sulfonamides and derivatives thereof that modulate the activity of endothelin

Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists

Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists

Carboxylic acid derivatives that inhibit the binding of integrins to their receptors

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD

Pyridino[1,2-A]pyrimidone analogue used as P13K inhibitor

Diarylthiohydantoin compound as androgen receptor antagonist

Diarylthiohydantoin compound as androgen receptor antagonist

FUJIAN COSUNTER PHARMACEUTICAL CO LTD

ASK1 inhibitor and preparation method and use thereof

Crystal form as ASK1 inhibitor and preparation method and application thereof

Pyridine derivative as ASK1 inhibitor and preparation method and use thereof

GLAXOSMITHKLINE IP DEV LTD

Compounds as rearranged during transfection (RET) inhibitors

Compounds as rearranged during transfection (RET) inhibitors

IMMUNOPHARMACEUTICS INC

N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin

N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin

CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD

Thienodiazepine derivatives and application thereof

BRD4 inhibitor compound in solid form and preparation method therefor and use thereof

D3 BIO WUXI CO LTD

Spiro compound serving as ERK inhibitor, and application thereof

Thiazololactam compound as ERK inhibitor and use thereof

MEDSHINE DISCOVERY INC

Heterocyclic compound

Glucoside derivative that acts as SGLT1 inhibitor and application thereof

TEXAS BIOTECHNOLOGY

Benzenesulfonamides and the use thereof to modulate the activity of endothelin

HANGZHOU SCIWIND BIOSCIENCES CO LTD

Five-membered heteroaryl-fused imidazole compound and application thereof

SHENZHEN SALUBRIS PHARM CO LTD

Piperidine compounds as PCSK9 inhibitors

CGENETECH SUZHOU CHINA CO LTD

SGLT2/DPP4 inhibitor and application thereof

PFIZER

Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists

HUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC

BTK inhibitor

CHINA RESOURCES BIOPHARMACEUTICAL COMPANY LTD

Macrocyclic derivatives acting as XIa factor inhibitor